Therapeutic potential of Chirabilva (Holopteliaintegrifolia planch): A critical review from Ayurveda classical literature

Gaurang Prajapati, Swati Gavadiya, Tarun Sharma, V. Bapna
{"title":"Therapeutic potential of Chirabilva (Holopteliaintegrifolia planch): A critical review from Ayurveda classical literature","authors":"Gaurang Prajapati, Swati Gavadiya, Tarun Sharma, V. Bapna","doi":"10.4103/jism.jism_73_22","DOIUrl":null,"url":null,"abstract":"Introduction: Among the quarter of medical management, the drug is placed next to the physician in the chronology of importance. Chirabilva [Holoptelia integrifolia (Roxb.) Planch] is one of the best drugs, which can use internally and externally in many diseases. It is described right from the time of Charak Samhita and had a wide range of therapeutic effects. Many formulations are indicated in Gulma, Arsha, Prameha, Shoola, Grahani, Kandu, Kushtha, and Jwara. Also, in Bhavprakash it is indicated in the treatment of Vami, Pitta Arsha, Krumi, Kushtha, and Prameh.Aim: The aim of this work was to study the Ayurveda literature to collect information regarding the internal therapeutic uses of Chirabilva (Holopteliaintegrifolia Planch). Materials and Methods: A literature review of Chirabilva from Charak Samhita, Susruta Samhita, Bhaisajya Ratnavali, Bharat Bhaisajya Ratnavali, Yoga Ratnakara, Gada Nigraha, and other relevant literature, and various database regarding various formulations, dosage form, indications, and useful parts. Observation and Result: During the literature review, reviewed total 309 formulations, like, Mahatiktak Ghrita, Dhanvantar Ghrita, Putikadhya Ghrita, Kalyanaka Lavana, Himsradhya Ghrita, Abhaya Lavana, Chirbilvadi Kwatha, Chirbilvadhya Churna, Panchamrut Parpati, etc. in 20 different dosage forms of Chirabilva were cited to be recommended in 19 diseases which are Gulma, Arsha, Prameha, Shoola, Grahani, Kandu, Kushtha, Jwara, Pandu, Sotha, Krimi, Swasa, Apasmara, Unmada, Graha Roga, etc. Conclusion: Chirabilva is cited in 19 diseases in 20 different dosage forms. It is mainly indicated in Gulma Roga, Arsha Roga, and Shoola. Based on the outcome of this literature review, new formulations and dosage forms can be developed using this abundantly available medicinal plant.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"14 1","pages":"30 - 40"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Indian System of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jism.jism_73_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Among the quarter of medical management, the drug is placed next to the physician in the chronology of importance. Chirabilva [Holoptelia integrifolia (Roxb.) Planch] is one of the best drugs, which can use internally and externally in many diseases. It is described right from the time of Charak Samhita and had a wide range of therapeutic effects. Many formulations are indicated in Gulma, Arsha, Prameha, Shoola, Grahani, Kandu, Kushtha, and Jwara. Also, in Bhavprakash it is indicated in the treatment of Vami, Pitta Arsha, Krumi, Kushtha, and Prameh.Aim: The aim of this work was to study the Ayurveda literature to collect information regarding the internal therapeutic uses of Chirabilva (Holopteliaintegrifolia Planch). Materials and Methods: A literature review of Chirabilva from Charak Samhita, Susruta Samhita, Bhaisajya Ratnavali, Bharat Bhaisajya Ratnavali, Yoga Ratnakara, Gada Nigraha, and other relevant literature, and various database regarding various formulations, dosage form, indications, and useful parts. Observation and Result: During the literature review, reviewed total 309 formulations, like, Mahatiktak Ghrita, Dhanvantar Ghrita, Putikadhya Ghrita, Kalyanaka Lavana, Himsradhya Ghrita, Abhaya Lavana, Chirbilvadi Kwatha, Chirbilvadhya Churna, Panchamrut Parpati, etc. in 20 different dosage forms of Chirabilva were cited to be recommended in 19 diseases which are Gulma, Arsha, Prameha, Shoola, Grahani, Kandu, Kushtha, Jwara, Pandu, Sotha, Krimi, Swasa, Apasmara, Unmada, Graha Roga, etc. Conclusion: Chirabilva is cited in 19 diseases in 20 different dosage forms. It is mainly indicated in Gulma Roga, Arsha Roga, and Shoola. Based on the outcome of this literature review, new formulations and dosage forms can be developed using this abundantly available medicinal plant.
藏红花(Holopteliaintegrifolia planch)的治疗潜力:从阿育吠陀经典文献综述
简介:在医疗管理的四分之一中,药物的重要性仅次于医生。Chirabilva [Holoptelia integrgrifolia (robb .)]是最好的药物之一,内服外用治疗许多疾病。它被描述从查拉克Samhita的时间,并有广泛的治疗效果。Gulma, Arsha, Prameha, Shoola, Grahani, Kandu, kustha和Jwara都有许多配方。此外,在Bhavprakash中,它被用于治疗Vami, Pitta Arsha, Krumi, Kushtha和Prameh。目的:本研究的目的是研究阿育吠陀文献,以收集有关藏红花(Holopteliaintegrifolia Planch)内部治疗用途的信息。材料与方法:文献综述了《查拉克·萨姆塔》、《苏鲁塔·萨姆塔》、《婆罗伽·罗特那瓦利》、《婆罗伽·罗特那瓦利》、《瑜伽·罗特那卡拉》、《伽达·尼格拉哈》等相关文献,以及各种配方、剂型、适应症和有用部位的各种数据库。观察与结果:在文献回顾中,共回顾了309种制剂,如maatiktak Ghrita、Dhanvantar Ghrita、Putikadhya Ghrita、Kalyanaka Lavana、Himsradhya Ghrita、Abhaya Lavana、Chirbilvadi Kwatha、Chirbilvadhya Churna、Panchamrut Parpati等,并引用了20种不同剂型的Chirabilva,推荐用于Gulma、Arsha、Prameha、Shoola、Grahani、Kandu、Kushtha、Jwara、Pandu、Sotha、Krimi、Swasa、Apasmara、Unmada、Graha Roga等19种疾病。结论:栀子花以20种不同的剂型应用于19种疾病。主要表现在Gulma Roga、Arsha Roga和Shoola。根据本文献综述的结果,可以利用这种丰富的药用植物开发新的配方和剂型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信